Trial intelligence / Profile preview

Lidocaine and Steroids for Pain Management in SAH Patients

NCT07294118Phase 2Recruiting

Sponsor
The University of Texas Medical Branch at Galveston
Start
Jan 2026
Primary completion
Jun 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lidocaine in Headache, subarachnoid hemorrhage (SAH), sponsored by The University of Texas Medical Branch at Galveston. Started Jan 2026; status: recruiting.

02

Drugs

lidocaine
03

Conditions

Headachesubarachnoid hemorrhage (SAH)

Beyond the preview

Go deeper on NCT07294118.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07294118.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call